As fitness wearables and sensors become more pervasive, important questions remain about privacy and the usefulness of health data tracking
From the instant he wakes up each morning, through his workday and into the night, the essence of Larry Smarr is captured by a series of numbers …
Context & Ripple Effects
When the Washington Post profiled Larry Smarr in 2015, quantified-self living was still a fringe experiment: one man streaming his body into dashboards. The decade of coverage since shows that experiment scaling into a market — AI-driven hyperpersonalized training is now a mainstream pursuit among fitness obsessives, while Oura and Whoop are large enough to weigh IPOs.
What has not kept pace is governance. The privacy questions this article raised about Smarr's own data became political with Senator Klobuchar's letter to HHS over Amazon's "intrusive" Halo tracker, and consumer ambivalence persists — the latest AI pendants are praised as useful and dismissed as creepy in the same reviews. Smarr's routine was the preview; regulation and business models are still catching up.
First-order effects
- Wearable makers like Oura, Whoop, and Amazon collect continuous physiological data from millions of users under health-data rules that Klobuchar's HHS letter showed are too thin to reassure them.
Second-order effects
- Investors price the category cautiously — the same coverage pairing Oura's and Whoop's IPO ambitions also flags Fitbit's struggles and low hardware margins, so data services rather than devices carry the growth case.
Third-order effects
- If continuous body sensing keeps expanding from fitness bands to AR glasses and always-on pendants, sensors themselves become the trust boundary consumers must evaluate — pushing health-data safeguards toward formal regulatory treatment rather than terms-of-service discretion.
The trend: Body tracking is moving from individual experiment to platform industry, with privacy governance lagging one product generation behind the sensors.